Home/Nanobiotix/Margaret A. Liu, MD

MA

Margaret A. Liu, MD

Supervisory Board Member

Therapeutic Areas

Nanobiotix Pipeline

Drug	Indication	Phase
NBTXR3	Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)	Phase III
NBTXR3 + anti-PD-1	Solid Tumors	Phase I
Curadigm Platform Programs	Undisclosed	Discovery/Preclinical

Leadership Team at Nanobiotix

Laurent Levy, PhD

Chief Executive Officer

Chief Financial and Business Officer

Anne-Juliette Hermant

Chief People Officer

Louis Kayitalire, MD

Chief Medical Officer

Anne-Sophie Larivière

Vice President, Strategy & Operational Excellence

Vice President, Strategic Marketing and Corporate Communications

Gary M. Phillips, MD

Chairman of Supervisory Board

Alain Herrera, MD

Supervisory Board Member

Supervisory Board Member

Anne-Marie Graffin

Supervisory Board Member

View full Nanobiotix profile